Kory James Wentworth - 16 Aug 2022 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Financial Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
16 Aug 2022
Net transactions value
-$7,184
Form type
4
Filing time
18 Aug 2022, 18:53:47 UTC
Previous filing
06 Jul 2022
Next filing
23 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Options Exercise $210 +100 +0.49% $2.10* 20,641 16 Aug 2022 Direct F1
transaction TRDA Common Stock Sale $2,600 -200 -0.97% $13.00 20,441 16 Aug 2022 Direct F1
transaction TRDA Common Stock Options Exercise $210 +100 +0.49% $2.10* 20,541 17 Aug 2022 Direct F1
transaction TRDA Common Stock Sale $2,614 -200 -0.97% $13.07 20,341 17 Aug 2022 Direct F1
transaction TRDA Common Stock Options Exercise $210 +100 +0.49% $2.10* 20,441 18 Aug 2022 Direct F1
transaction TRDA Common Stock Sale $2,600 -200 -0.98% $13.00 20,221 18 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Options Exercise $0 -100 -0.09% $0.000000 116,096 16 Aug 2022 Common Stock 100 $2.10 Direct F1, F2
transaction TRDA Stock Option (Right to Buy) Options Exercise $0 -100 -0.09% $0.000000 115,996 17 Aug 2022 Common Stock 100 $2.10 Direct F1, F2
transaction TRDA Stock Option (Right to Buy) Options Exercise $0 -100 -0.09% $0.000000 115,896 18 Aug 2022 Common Stock 100 $2.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
F2 25% of the shares subject to this option shall vest and become exercisable on November 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.